Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Entero Healthcare IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2018 Industry: Trading Listed Page

Profile
Issue Size --
Profile
Price Range 1195  to  1258 per share
Profile
Min Investment ₹1258
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Entero Healthcare Solutions Limited is a prominent healthcare technology company based in India. Specializing in healthcare informatics and software solutions, Entero offers a comprehensive suite of products and services aimed at optimizing healthcare delivery and management. The company's offerings include electronic health records (EHR) systems, hospital management software, telemedicine solutions, and data analytics platforms. By leveraging cutting-edge technology and industry expertise, Entero Healthcare Solutions empowers healthcare providers to streamline operations, improve patient care, and enhance overall efficiency. With a focus on innovation and customer satisfaction, the company collaborates closely with healthcare institutions, government agencies, and industry partners to address the evolving needs of the healthcare sector. Entero's commitment to quality, reliability, and scalability has positioned it as a trusted partner for healthcare organizations seeking to leverage technology to drive better patient outcomes and operational excellence. Read More

Basic Info

Face Value 10 per share

Price 1195  to  1258 per share

P/E (x) 57.7

Sales( Cr.) 5096

PAT( Cr.) 107

EPS 21.8

Draft Prospectus --

Exchange BSE-NSE

Promoter

Company Promoters

Prabhat Agrawal Prem Sethi OrbiMed Asia III Mauritius Limited.

Pre Issue Share Holding 77.11%

Post Issue Share Holding --%

Listing Details:

Listing Price: 1245

Listing Gain: -1.04%

Current Price: 1195.8

Gain On Issue: 1195.8 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Feb 09, 2024
Closing Date Feb 13, 2024
Allotment Feb 14, 2024
Refund Feb 15, 2024
Delivery of Shares Feb 15, 2024
Listing Date Feb 16, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 11 13,838
Retail (Max) 14 154 193,732
S-HNI (Min) 15 165 207,570
S-HNI (Max) 72 792 996,336
B-HNI (Min) 73 803 1,010,174

Objective of the Issue

1. Repayment/prepayment, in full or part, of certain borrowings availed of by the company and our Subsidiaries. 2. Funding the long term working capital requirements. 3. Pursuing inorganic growth initiatives through acquisitions. 4. General corporate purposes.

Issue

Category Nos Bid Bid (x)
QIB 9538950 21844196 2.3x
NII 1907790 419714 0.2x
Retail 1271860 1170111 0.9x
EMP 0 0 0x
Total 12718600 18187598 1.4x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Entero Healthcare Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1780 2522 3300 3922 5096
Other Income 4 4 6 14 40
Total Income 1784 2527 3306 3937 5135
Total Expenditure 1758 2498 3236 3810 4924
Operating Profit 25 29 70 126 211
Interest 20 29 49 66 42
Depreciation 16 20 24 25 31
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax -11 -20 -4 36 139
Provision for Tax 5 10 7 -4 31
Profit After Tax -15 -29 -11 40 107
Adjustments -0 -0 -0 -1 -13
Profit After Adjustments -16 -30 -12 39 95
Adjusted Earnings Per Share -1553.7 -77.7 -28.1 9 21.8

Entero Healthcare Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 485 561 595 1638 1724
Minority's Interest 2 2 3 3 46
Borrowings 0 37 31 46 0
Other Non-Current Liabilities 57 63 54 37 73
Total Current Liabilities 289 462 624 602 845
Total Liabilities 833 1125 1307 2326 2688
Fixed Assets 189 262 268 289 559
Other Non-Current Assets 12 12 16 26 53
Total Current Assets 633 851 1023 2011 2076
Total Assets 833 1125 1307 2326 2688

Entero Healthcare Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 43 32 47 25 148
Cash Flow from Operating Activities -69 -35 -45 -37 -77
Cash Flow from Investing Activities -31 -162 -49 -705 220
Cash Flow from Financing Activities 89 211 73 863 -74
Net Cash Inflow / Outflow -11 14 -21 121 69
Closing Cash & Cash Equivalent 32 47 25 148 229

Entero Healthcare Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -1553.7 -77.71 -28.11 8.99 21.79
CEPS(Rs) 92.2 -25.16 31.94 14.9 31.75
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) -3174.6 -150.52 -166.8 376.21 395.31
Core EBITDA Margin(%) 1.21 0.97 1.94 2.85 3.37
EBIT Margin(%) 0.52 0.36 1.37 2.58 3.54
Pre Tax Margin(%) -0.61 -0.79 -0.11 0.91 2.72
PAT Margin (%) -0.86 -1.17 -0.34 1.01 2.11
Cash Profit Margin (%) 0.05 -0.38 0.4 1.65 2.71
ROA(%) -1.84 -3.01 -0.91 2.19 4.29
ROE(%) 0 0 0 5.08 6.4
ROCE(%) 1.47 1.24 4.99 7.02 9.16
Receivable days 49.66 44.63 49.19 52.59 51.78
Inventory Days 50.03 40.09 36.04 35.49 38.71
Payable days 21.55 18.67 21.08 22.51 24.83
PER(x) 0 0 0 109.53 52.15
Price/Book(x) 0 0 0 2.62 2.88
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.32 0.32 0.28 0.93 0.98
EV/Core EBITDA(x) 22.61 27.75 13.45 29.04 23.61
Net Sales Growth(%) 0 41.71 30.85 18.85 29.92
EBIT Growth(%) 0 -0.36 393.99 123.56 78.15
PAT Growth(%) 0 -91.74 62.28 458.42 169.94
EPS Growth(%) 0 95 63.83 131.99 142.37
Debt/Equity(x) 0.29 0.51 0.63 0.17 0.17
Current Ratio(x) 2.19 1.84 1.64 3.34 2.46
Quick Ratio(x) 1.35 1.17 1.09 2.64 1.68
Interest Cover(x) 0.46 0.32 0.92 1.54 4.33
Total Debt/Mcap(x) 0 0 0 0.06 0.06

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 30% 26% 0% 0%
Operating Profit CAGR 67% 94% 0% 0%
PAT CAGR 168% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -7% NA% NA% NA%
ROE Average 6% 4% 2% 2%
ROCE Average 9% 7% 5% 5%

Company Contact Information

Entero Healthcare Solutions Ltd.

Plot No. I-35, Building - B Industrial Area Phase - I 13/7 Mathura Road

IPO Lead Manager(s)

Entero Healthcare Solutions Ltd.

Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.)

ICICI Securities Ltd

Jefferies India Pvt Ltd.

JM Financial Ltd.

SBI Capital Markets Ltd

Registrar Info

Entero Healthcare Solutions Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!